Lv1
80 积分 2023-12-06 加入
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
29天前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1个月前
已完结
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
1个月前
已完结
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
1个月前
已关闭
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity
1个月前
已完结
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
2个月前
已完结
LB1008 KLK5/7 targeting antibody, TRIV-509, ameliorates barrier dysfunction, inflammation and itch in atopic dermatitis models
2个月前
已关闭
Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
2个月前
已完结
267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
2个月前
已完结
Type I interferon–related kidney disorders
2个月前
已完结
皖公网安备34019202002308
